Trial Details
RecruitingBasic Information
| Clinical ID | c5523 |
|---|---|
| Identifier | NL-OMON20310 |
| Trial Title | Lengthening Adalimumab Dosing Interval in IBD patients in long term remission, theLADI study. |
| Trial URL | Visit Original Page |
Study Information
| Study Results | NULL |
|---|---|
| Conditions | Crohn's DiseaseUlcerative ColitisInflammatory Bowel DiseaseAdalimumab |
| Interventions | Intervention: adalimumab 40mg every 21 days Control: adalimumab 40mg every 14 days |
Participant Information
| Sponsor | Erasmus MC |
|---|---|
| City | NULL |
| Country/Region | NULL |
Enrollment Criteria
| Sex Requirement | NOT SPECIFIED |
|---|---|
| Age Requirement | NULL |
Study Design
| Study Type | Interventional |
|---|---|
| Phase | NULL |
Time Information
| Start Date | NULL |
|---|---|
| Primary Completion Date | NULL |
| Completion Date | NULL |